Seasonal Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Seasonal Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-08-31Clinical Trial Update: Probiotics and Health-related Quality of Life in Individuals With Seasonal Allergies [NA]
This clinical trial update reports completion of a study evaluating whether probiotics influence health-related quality of life in individua…
-
CLINICAL_TRIALS trial_result · 2016-05-30Clinical Trial Update: Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204) [Phase 3]
A Phase 3 trial update reports efficacy and safety results for desloratadine (MK-4117) in Japanese participants with Seasonal Allergic Rhini…
-
CLINICAL_TRIALS trial_result · 2016-05-23Clinical Trial Update: Efficacy and Safety of Sublingual Tablets of Grass Pollen Allergen Extract [Phase 1]
Phase 1 clinical trial evaluating the safety and efficacy of sublingual grass pollen allergen extract tablets for seasonal allergic rhinitis…
-
CLINICAL_TRIALS trial_result · 2016-04-11Clinical Trial Update: Efficacy and Safety of SPARC1310 in Seasonal Allergic Rhinitis [Phase 2]
Phase 2 trial results for SPARC1310 in seasonal allergic rhinitis have been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2016-01-18Clinical Trial Update: Safety Study of MK-3641 and MK-7243 Co-administered in Adult Participants With Ragweed and Grass Pollen Induced Allergic Rhinitis (P08607, MK-3641-006) [Phase 4]
This clinical trial update reports the results of a Phase 4 safety study evaluating co-administration of MK-3641 and MK-7243 in adults with …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-12-22Clinical Trial Update: MK0524 Seasonal Allergic Rhinitis Study (0524-005)(COMPLETED) [Phase 2]
This record notes the completion of Merck's Phase 2 MK0524 trial for seasonal allergic rhinitis (NCT00533208).
-
CLINICAL_TRIALS trial_result · 2015-12-08Clinical Trial Update: Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Immunotherapy)-Tablet in Adult Subjects With Grass Pollen-induced Allergic Rhinoconjunctivitis [Phase 3]
Completed Phase 3 trial evaluating the immunology and safety of a 60-day course of SQ Grass SLIT-Tablet in adults with grass pollen–induced …
-
CLINICAL_TRIALS trial_result · 2015-11-02Clinical Trial Update: Study of the Effect of SCH 900538 on Congestion in Subjects With Seasonal Allergic Rhinitis (Study P05031)(COMPLETED) [Phase 2]
A Phase 2 clinical trial (Study P05031) evaluating SCH 900538 for congestion in seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2015-11-02Clinical Trial Update: Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis [Phase 3]
A Phase 3 trial comparing the therapeutic equivalence of a mometasone furoate nasal spray (50 mcg) with Nasonex nasal spray for seasonal all…
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis [Phase 2]
Phase 2 trial evaluating epinastine nasal spray for Seasonal Allergic Rhinitis has completed. The study assessed safety and efficacy in affe…
-
CLINICAL_TRIALS trial_result · 2015-08-14Clinical Trial Update: Tolerability/Safety of Intranasal AZD8848 in Healthy Male Volunteers and Seasonal Allergic Rhinitis Male Patients Out of Season [Phase 1]
This Phase 1 study assessed the tolerability and safety of intranasal AZD8848 in healthy male volunteers and in male patients with seasonal …
-
CLINICAL_TRIALS trial_result · 2015-06-29Clinical Trial Update: Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR) [Phase 3]
Phase 3 trial of Dymista nasal spray in children aged 4-11 with seasonal allergic rhinitis has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Grass Pollen Subcutaneous Immunotherapy in Elderly Patients [Phase 4]
Phase 4 trial completed evaluating grass pollen subcutaneous immunotherapy in elderly patients with grass pollen allergy. The study focused …
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Trial With Rhinitic Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber [Phase 2]
A Phase 2 study comparing GSK256066 to placebo in patients with seasonal allergic rhinitis/allergic rhinitis has completed, based on a polle…
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: Study of Grass-SPIRE in Subjects With Grass Allergies and Asthma [Phase 2]
Circassia Limited announced the completion of its Grass-SPIRE Phase 2 trial in subjects with seasonal allergic rhinitis and asthma. The stud…
-
CLINICAL_TRIALS trial_result · 2015-03-20Clinical Trial Update: Evaluating the Efficacy of Ragweed-SPIRE Following Exposure to Ragweed Allergen in an Environmental Exposure Chamber [Phase 2]
A Phase 2 trial evaluating the efficacy of Ragweed-SPIRE for seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2015-02-20Clinical Trial Update: Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies [Phase 3]
Phase 3 clinical trial in children aged 6-11 comparing an investigational nasal aerosol to placebo for seasonal allergic rhinitis; results h…
-
CLINICAL_TRIALS trial_result · 2015-02-13Clinical Trial Update: Observation of Use of Claritin (Loratadine) Tablet, RediTabs, and Dry Syrup in Children (Study P05834)(COMPLETED)
This clinical trial update describes observational usage of Loratadine (Claritin) in pediatric patients using tablet, RediTabs, and dry syru…
-
CLINICAL_TRIALS trial_result · 2015-01-21Clinical Trial Update: Safety Study of Ragweed-SPIRE in Subjects With Ragweed Allergies and Asthma [Phase 2]
A Phase 2 safety study of Ragweed-SPIRE in subjects with ragweed allergies and asthma has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Efficacy Park Study Assessing Rhinix™ Nasal Filters for Hay Fever [NA]
A completed clinical trial evaluated the efficacy of Rhinix nasal filters for seasonal allergic rhinitis (hay fever).
-
CLINICAL_TRIALS trial_result · 2014-11-11Clinical Trial Update: Compliance and Usability Study Evaluating RHINIX™ Nasal Filters [NA]
A completed usability and compliance study evaluating RHINIX nasal filters for seasonal allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2014-10-31Clinical Trial Update: A Study Comparing the Bioequivalence of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Apotex, Inc.) to That of Dymista™ Nasal Spray (Meda Pharmaceuticals, Inc.) in the Treatment of Seasonal Allergic Rhinitis [Phase 2]
A Phase 2 trial evaluating the bioequivalence of Apotex's azelastine hydrochloride and fluticasone propionate nasal spray to Dymista for sea…
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: A Study Comparing The Bioequivalence Of Ciclesonide Nasal Spray (Apotex, Inc.) To That Of Omnaris™ Nasal Spray (Sepracor, Inc.) In The Treatment Of Seasonal Allergic Rhinitis [Phase 3]
A Phase 3 trial comparing the bioequivalence of Apotex's ciclesonide nasal spray to Omnaris nasal spray in seasonal allergic rhinitis has co…
-
CLINICAL_TRIALS trial_result · 2014-10-09Clinical Trial Update: Vitamin D Plus Fluticasone Propionate [Phase 4]
Phase 4 clinical trial of vitamin D in combination with fluticasone propionate for seasonal allergic rhinitis has completed and results have…
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™ [Phase 3]
A Phase 3 trial is evaluating whether a nasal spray containing azelastine hydrochloride and fluticasone propionate (137/50 mcg) is clinicall…